ACC.17 Anticoagulants Compared in A-fib Patients Undergoing Catheter Ablation Publish Date March 20, 2017 Study patients were randomized to Pradaxa 150mg twice daily or warfarin (target INR 2-3) and remained on this treatment for the trial duration.
ACC.17 Edoxaban Use May be Safe for Patients Undergoing A-fib Ablation Publish Date March 17, 2017 Jan Steffel, from the TIMI Study Group, Boston, MA, and colleagues presented on the safety of edoxaban in the context of atrial fibrillation (AF) ablation.